Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
McKesson Plasma and Biologics is a specialized business unit of McKesson Corporation dedicated to the distribution and supply chain management of plasma-derived therapies and biologics. The company provides healthcare providers with reliable access to critical products such as intravenous immunoglobulin (IVIG), albumin, coagulation factors, and specialty vaccines. By leveraging McKesson's extensive logistics infrastructure, the division ensures the integrity of temperature-sensitive medications through advanced cold-chain solutions. Additionally, they offer clinical resources and inventory management tools to help optimize patient care and operational efficiency for hospitals and specialty clinics. Their services support a wide range of therapeutic areas including immunology, hematology, and neurology. As a leader in specialty distribution, they serve as a vital link between biopharmaceutical manufacturers and the point of care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on McKesson Plasma and Biologics.